Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Medicaid Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Emergency Room Boarding
  • Device Coverage by Medicare
  • Planned Parenthood Funding
  • Covid/Flu Combo Shot
  • RFK Jr. vs. Congress

TRENDING TOPICS:

  • Emergency Room Boarding
  • Device Coverage by Medicare
  • Planned Parenthood Funding
  • Covid/Flu Combo Shot
  • RFK Jr. vs. Congress

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Sep 21 2023

Full Issue

Neuralink, Elon Musk's Brain-Chip Startup, Readies To Start Human Trials

The first human clinical trial for Neuralink's brain-computer interface is expected to take 6 years and will recruit participants who have quadriplegia with limited function in all four limbs due to a spinal cord injury or ALS.

Reuters: Musk's Neuralink To Start Human Trial Of Brain Implant For Paralysis Patients

Billionaire entrepreneur Elon Musk's brain-chip startup Neuralink said on Tuesday it has received approval from an independent review board to begin recruitment for the first human trial of its brain implant for paralysis patients. Those with paralysis due to cervical spinal cord injury or amyotrophic lateral sclerosis may qualify for the study, it said, but did not reveal how many participants would be enrolled in the trial, which will take about six years to complete. (9/20)

USA Today: Elon Musk's Neuralink Is Ready To Embark On Its First Clinical Trial. Here's How To Sign Up

The search for human participants is on as Neuralink embarks on its first clinical trial, the company announced Tuesday. Neuralink, a tech startup owned and co-founded by Elon Musk, received FDA approval in May to implant brain chips into humans. (Encinas and Snider, 9/20)

Wired: The Gruesome Story Of How Neuralink’s Monkeys Actually Died 

Elon Musk says no primates died as a result of Neuralink’s implants. A WIRED investigation now reveals the grisly specifics of their deaths as US authorities have been asked to investigate Musk’s claims. (Mehrotra and Cameron, 9/20)

It's World Alzheimer's Day —

NPR: A Heartwarming Connection Among Music, Memory And Alzheimer's

After 18 years of living with Alzheimer's disease, Marti Kaye spends most of her time in a wheelchair, expressionless. That changes the minute her son Adam Kaye starts playing his guitar. (Jones, 9/21)

The Washington Post: Dental Health Can Affect Your Brain And Is Linked To Dementia, Alzheimer’s

Poor oral hygiene is associated with an increased risk for myriad health problems, including heart disease, diabetes, cancer, rheumatoid arthritis and early death. The state of our teeth and gums, though, may be vital for our well-being beyond the mouth and body. Emerging evidence suggests that what goes on in our mouth can affect what goes on in our brain — and may even potentially affect our risk for dementia. (Sima, 9/21)

In other research news —

Stat: They Carry A Gene For ALS But Aren’t Sick. What Does Medical Research Owe Them?

A new movement is pushing the medical and research world to include people with genetic mutations for ALS for the first time. (Mast, 9/21)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, April 24
  • Thursday, April 23
  • Wednesday, April 22
  • Tuesday, April 21
  • Monday, April 20
  • Friday, April 17
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF